A Theranostic Study of (177)Lu-Labeled Anti-ADAM9 Antibody for the Treatment of Triple-Negative Breast Cancer.

Zhang H, Tang M, Hao X, Lin B, Du H, Long H, Hu J, Luo R, Wu W, Du X

DOI: 10.1021/acs.bioconjchem.6c00126
Published: 2026 Jun 17
Container: Bioconjugate chemistry
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acs.bioconjchem.6c00126,
  title = {A Theranostic Study of (177)Lu-Labeled Anti-ADAM9 Antibody for the Treatment of Triple-Negative Breast Cancer.},
  author = {Zhang H and Tang M and Hao X and Lin B and Du H and Long H and Hu J and Luo R and Wu W and Du X},
  year = {2026},
  journal = {Bioconjugate chemistry},
  doi = {10.1021/acs.bioconjchem.6c00126},
  url = {https://doi.org/10.1021/acs.bioconjchem.6c00126}
}

RIS

TY  - JOUR
TI  - A Theranostic Study of (177)Lu-Labeled Anti-ADAM9 Antibody for the Treatment of Triple-Negative Breast Cancer.
AU  - Zhang H
AU  - Tang M
AU  - Hao X
AU  - Lin B
AU  - Du H
AU  - Long H
AU  - Hu J
AU  - Luo R
AU  - Wu W
AU  - Du X
PY  - 2026
JO  - Bioconjugate chemistry
DO  - 10.1021/acs.bioconjchem.6c00126
UR  - https://doi.org/10.1021/acs.bioconjchem.6c00126
ER  -

APA

H, Z., M, T., X, H., B, L., H, D., H, L., J, H., R, L., W, W., & X, D. (2026). A Theranostic Study of (177)Lu-Labeled Anti-ADAM9 Antibody for the Treatment of Triple-Negative Breast Cancer.. Bioconjugate chemistry. https://doi.org/10.1021/acs.bioconjchem.6c00126

Source records

pubmed · retrieved 2026-09-26T18:22:30.482Z